Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 500 enheder

Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

abacus medicine a/s - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 500 enheder

União Europeia - dinamarquês - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - clostridium botulinum, type a toxin-haemagglutinin compleks - pulver til injektionsvæske, opløsning - 300 enheder

União Europeia - dinamarquês - EMA (European Medicines Agency)

billev pharma aps - lutetium (177lu) chloride - radionuklidbilleddannelse - terapeutiske radioaktive lægemidler - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

União Europeia - dinamarquês - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 500 enheder

Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - clostridium botulinum, type a toxin-haemagglutinin compleks - pulver til injektionsvæske, opløsning - 300 enheder

União Europeia - dinamarquês - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologiske - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.